INNOVA is a niche CRO in the Middle East and North African region, focused mainly on immunology, hematology, oncology and rare diseases. Established by a group of experts in research and development who worked for multinational pharmaceutical companies, INNOVA’s team understands the needs of global sponsors and possesses the expertise required to meet those needs. Our knowledge of the local regulations and culture, in addition to our extensive investigator network, enables us to plan and implement our clinical trials successfully. At INNOVA, we understand the challenges of every clinical study that we manage, and strive to overcome these challenges through intelligent, novel, and valuable solutions.
